5 Stocks Exploding in a Bleeding Market

4. Tevogen Bio Holdings Inc. (NASDAQ:TVGN)

Tevogen rallied for a third day on Monday, climbing 11.26 percent to finish at $7.41 apiece, as investor sentiment was fueled by news that it is now gearing up for the commercialization of its AI training algorithm designed to identify immunologically active peptides.

Called PredicTcell, Tevogen Bio Holdings Inc. (NASDAQ:TVGN) said in a statement last week that the training algorithm is now in the final stages of its training phase.

The model has been trained on one of the industry’s largest curated peptide datasets, with feature expansion now exceeding 180 parameters, contributing to an approximate 10 percent improvement in precision.

“As development progresses, the Company has begun evaluating potential co-development partnerships to support broader application of the platform. These efforts are grounded in addressing a fundamental challenge in drug development, high-confidence target identification, which today often requires significant wet lab validation. By leveraging advanced predictive modeling, Tevogen.AI aims to reduce development timelines, material costs, and overall experimental burden,” Tevogen Bio Holdings Inc. (NASDAQ:TVGN) said.

To support this transition, Tevogen.AI has developed an initial version of an internal application and portal designed to serve the PredicTcell model in a scalable and user-friendly environment. The system is intended to streamline internal workflows while also serving as the foundation for a potential future customer-facing platform.